We are a dedicated team with proven expertise and success in translational research, medicines discovery and clinical development
Jean is currently a non-executive director at Epics Therapeutics SA, having previously served as its founding CEO from 2017. Jean was Chair of the Board at Syndesi Therapeutics SA from 2018 until its sale to AbbVie in 2022. Previously, he was CEO of Ogeda SA from 2006 until its sale to Astellas Pharma Inc. in 2017.
Earlier in his career, Dr Combalbert held senior positions with Sanofi and Galderma in France and the United States.
Prior to joining Epidarex, Liz was Head of Business Development and part of the management team at Chroma Therapeutics Ltd., an Oxford-based venture-backed drug discovery and development company focused on inflammatory disorders and oncology. Liz led the establishment of several major company-building alliances including a multi‐target deal with GlaxoSmithKline around Chroma’s novel platform. Liz is a former executive with the life science venture capital team at the Investments Division of The Wellcome Trust. She is also a former member of the life Science team at Atlas Ventures, London.
Liz currently serves on the Board of Directors of AdoRx Ltd. (Chair), Dunad Ltd. (Chair), Nodthera Ltd., Mironid Ltd,., Exeed Ltd. (Chair), EM Imaging Ltd and Macomics Ltd. She holds a B.Sc. (Hons) in Biochemistry (1st class) from the University College Cork, and a Ph.D. from the Imperial Cancer Research Fund.
Kynos Therapeutics Ltd.
Enterprise Hub 2.14
Murchison House
King's Buildings
10 Max Born Crescent
Edinburgh EH9 3BF
United Kingdom